Asia Pacific Blood Screening Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2029 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
|
亚太血液筛查市场，按产品和服务（试剂和试剂盒、仪器、软件和服务）、技术（核酸检测、酶联免疫吸附测定、快速检测、蛋白质印迹测定、下一代测序等）、疾病类型（呼吸系统疾病、糖尿病、肿瘤学、胆固醇、艾滋病毒/艾滋病、感冒和流感、传染病等）、最终用户（诊断中心、血库、医院、诊所、门诊手术中心）、国家（日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区）划分 - 行业趋势和预测至 2029 年
市场分析与洞察 亚太血液筛查市场
预计在 2022 年至 2029 年的预测期内，血液筛查市场将以 7.99% 的速度增长。Data Bridge Market Research 关于血液筛查市场的报告提供了有关预测期内预计会盛行的各种因素的分析和见解，同时提供了它们对市场增长的影响。患者对向重症患者献血的意识的提高正在加速血液筛查市场的增长。
血液筛查基本上是指对血液样本进行的医学测试，用于诊断多种疾病，包括肝炎、梅毒、艾滋病和妊娠等其他临床状况。此外，它还有助于监测疾病，避免健康问题和其他疾病的变化，包括感染和癌症。
预计在预测期内推动血液筛查市场增长的主要因素是新型 病原体流行率的上升。此外，老年人口的增加预计将进一步推动血液筛查市场的增长。此外，对先进技术开发的投资水平不断提高预计将缓冲血液筛查市场的增长。另一方面，替代技术预计将进一步阻碍血液筛查市场在预测期内的增长。
此外，自仪器推出以来，消费者的采用和接受率不断提高，这将为未来几年血液筛查市场的增长提供潜在机会。然而，血液采样成本的不断增长可能会在不久的将来进一步挑战血液筛查市场的增长。
This blood screening market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the blood screening market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Blood Screening Market Scope and Market Size
The blood screening market is segmented on the basis of products and services, technology, disease type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications.
- On the basis of products and services, the blood screening market is segmented into reagents and kits, instruments and software and services. Reagents and kits are further sub-segmented into NAT reagents and kits, ELISA reagents and kits others as well. NAT reagents is further sub-segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labelling and detection reagents. ELISA reagents and kits is further sub-segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments and purchase type.
- On the basis of technology, the blood screening market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub-segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA market, by platform is further sub-segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above.
- On the basis of disease type, the blood screening market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold and flu, infectious diseases and others.
- On the basis of end user, the blood screening market is segmented into diagnostic centers, blood bank, hospitals, clinics and ambulatory surgical centers.
Blood Screening Market Country Level Analysis
The blood screening market is analyzed, and market size insights and trends are provided by country, products and services, technology, disease type and end user as referenced above.
The countries covered in the blood screening market report are the China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
The country section of the blood screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The blood screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the blood screening market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the blood screening market. The data is available for the historic period 2010-2020.
Competitive Landscape and Blood Screening Market Share Analysis
The blood screening market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the blood screening market.
血液筛查市场的一些主要参与者包括 Enzo Biochem Inc.、Meridian Life Science.、BD、Bio-Rad Laboratories, Inc.、Thermo Fisher Scientific、BioMérieux SA、Beckman Coulter, Inc.、Abbott、F. Hoffmann-La Roche Ltd、Cepheid.、Grifols, SA、Siemens、Ortho Clinical Diagnostics、Immucor, Inc. 和 Hologic Inc. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
